Chemours (CC) Tops Q3 EPS by 28c; adj.-EBITDA Rose ~59%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
The Chemours Company Reports Third Quarter 2016 Results; Significant Earnings and Margins Increases Driven by Progress on Transformation Plan and Improved Market Conditions
November 6, 2016 4:30 PM ESTWILMINGTON, Del., Nov. 6, 2016 /PRNewswire/ --
Third Quarter 2016 Highlights
Net Sales of $1.4 billion Net Income of $204 million, or $1.11 per diluted share, including gain on asset sales of $169 million, impairment charges of $46 million, interest expense of $51 million and restructuring costs of $14 million Adjusted EBITDA of $268 million Adjusted Net Income of $112 million, or $0.61 per diluted shareOther Highlights
Continued progress on all transformation plan objectives, including cost reductions, growth initiatives and portfolio rationalization Improved cash from operating activities by ~$440 million year-to-date Retired $315 million of long term... More
